XBiotech Insider W. Thorpe McKenzie Holds 9.68% Stake

TL;DR

**Insider W. Thorpe McKenzie still owns 9.68% of XBiotech, a slight dip but still a big stake.**

AI Summary

W. Thorpe McKenzie, a significant insider at XBiotech Inc., filed an amended SC 13G/A on February 7, 2024, disclosing his beneficial ownership of 2,971,259 shares of XBiotech common stock as of December 31, 2023. This represents 9.68% of the company's outstanding shares, a slight decrease from previous filings. This matters to investors because it shows a key insider's continued, albeit slightly reduced, substantial stake in the company, which can signal confidence or a shift in their investment strategy.

Why It Matters

This filing indicates that a major insider, W. Thorpe McKenzie, still holds a significant portion of XBiotech, providing insight into his ongoing commitment to the company.

Risk Assessment

Risk Level: low — The filing indicates a stable, albeit slightly reduced, significant insider ownership, which generally doesn't introduce new risks.

Analyst Insight

Investors should note W. Thorpe McKenzie's continued substantial ownership (9.68%) in XBiotech Inc. as a sign of ongoing insider interest, but also recognize that this is an amendment, not a new position, and represents a slight adjustment rather than a major new investment or divestment.

Key Numbers

• 2,971,259 — Total Shares Owned (W. Thorpe McKenzie's aggregate beneficial ownership in XBiotech Inc.)
• 9.68% — Percentage of Class (The portion of XBiotech Inc.'s common shares beneficially owned by W. Thorpe McKenzie.)
• 2,864,971 — Sole Voting Power Shares (Shares over which W. Thorpe McKenzie has sole voting and dispositive power.)
• 106,288 — Shared Voting Power Shares (Shares over which W. Thorpe McKenzie has shared voting and dispositive power.)

Key Players & Entities

• W. Thorpe McKenzie (person) — Reporting Person, beneficial owner of XBiotech shares
• XBiotech Inc. (company) — The issuer of the securities
• 2,971,259 (dollar_amount) — Aggregate amount of shares beneficially owned by W. Thorpe McKenzie
• 9.68% (dollar_amount) — Percentage of class represented by W. Thorpe McKenzie's ownership
• December 31, 2023 (date) — Date of event requiring the filing

Forward-Looking Statements

• W. Thorpe McKenzie will maintain a significant, albeit potentially fluctuating, ownership stake in XBiotech Inc. above 5% for the foreseeable future. (W. Thorpe McKenzie) — high confidence, target: December 31, 2024

FAQ

Filing Documents

• sc13ga_020724.htm (SC 13G/A) — 47KB
• 0001171843-24-000654.txt ( ) — 48KB

From the Filing

SC 13G/A 1 sc13ga_020724.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 XBIOTECH INC. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 98400H102 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [ ] Rule 13d-1(c) [x] Rule 13d-1(d) 1 The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise ). SCHEDULE 13G CUSIP No. 98400H102 1 Names of Reporting Persons W. Thorpe McKenzie 2 Check the appropriate box if a member of a Group (see instructions) (a) [ ] (b) [ ] 3 Sec Use Only 4 Citizenship or Place of Organization USA Number of Shares 5 Sole Voting Power Beneficially Owned by 2,864,971 (1) Each Reporting Person 6 Shared Voting Power With: 106,288 (3) 7 Sole Dispositive Power 2,864,971 (1) 8 Shared Dispositive Power 106,288 (3) 9 Aggregate Amount Beneficially Owned by Each Reporting Person 2,971,259 (1)(2) 10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions) [ ] 11 Percent of class represented by amount in row (9) 9.68% (4) 12 Type of Reporting Person (See Instructions) IN Page 2 of 7 (1) These figures include shares of common stock underlying stock options held by the Reporting Person, including options that are immediately exercisable within 60 days of December 31, 2023. (2) Includes 66,748 shares held by the McKenzie Foundation, 31,864 shares held by Mr. McKenzie’s spouse and 7,676 shares held in a Trust for Mr. McKenzie’s stepchildren. (3) The Reporting Person’s spouse owns, controls and holds sole dispositive power to 31,864 shares for which the Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. The Reporting Person’s Foundation owns, controls and holds sole dispositive power to 66,748 shares for which the Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. The Reporting Person’s stepchildren owns, controls and holds sole dispositive power to 7,676 shares for which the Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. (4) The percentage is calculated based upon 30,436,964 shares outstanding as of December 31, 2023. Page 3 of 7 Item 1. (a) Name of Issuer: XBiotech Inc. (b) Address of Issuer’s Principal Executive Offices: 5217 Winnebago Ln, Austin, TX 78744 Item 2. (a) Name of Person Filing: W. Thorpe McKenzie (b) Address of Principal Business Office or, if None, Residence: 832 Georgia Avenue, Suite 1100 Chattanooga, TN 37402 (c) Citizenship: USA (d) Title and Class of Securities: Common Shares, no par value (e) CUSIP No.: 98400H102 Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) ◻ Broker or dealer registered under Section 15 of the Act; (b) ◻ Bank as defined in Section 3(a)(6) of the Act; (c) ◻ Insurance company as defined in Section 3(a)(19) of the Act; (d) ◻ Investment company registered under Section 8 of the Investment Company Act of 1940; (e) ◻ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) ◻ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) ◻ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) ◻ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) ◻ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940; (j) ◻ Group, in accordance with Rule 13d-1(b)(1)(ii)(J). Not Applicable Item 4. As of December 31, 2023 (a) Amount Beneficially Owned: 2,971,259 (1)(2) shares (b) Percent of Class: 9.68% (4) (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 2,864,971 (1) shares Page 4 of 7 (ii) Shared power

View Full Filing

View this SC 13G/A filing on SEC EDGAR